Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...

A new UK trial will screen thousands of high-risk adults for early liver disease in primary care, aiming to improve diagnosis ...

The U.S. is cutting the Hepatitis B vaccine from its recommended list. But here's a place where the medical establishment — ...

A new study co-led by the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and ...

Objective To examine the associations between the number of days per week achieving various daily step thresholds and all-cause mortality and cardiovascular disease (CVD) incidence in older women.

Scientists identify measurable cellular changes that flag higher cancer risk more than a decade before tumors appear. In A ...

KJ Muldoon received a groundbreaking new treatment earlier this year. The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead ...

The human small intestine absorbs nutrients while protecting us from potentially harmful microbes. One of the cell types that plays a key role in this protection is the microfold cell, or M cell.

Dec 8 (Reuters) - The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a severe form of fatty liver disease in drug trials, the ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...

Alzheimer's disease (AD) is one of the most common and challenging neurodegenerative diseases globally. It mostly affects older adults, causing irreversible changes in the brain that result in the ...